COMMUNIQUÉS West-GlobeNewswire

Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/06/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Market update : FOCUS-27 transformation project financing
06/06/2024
Press release Paris – June 6, 2024 – EUROAPI informs that it has decided to be assisted by a mandataire ad hoc in its discussions initiated in February 2024 regarding the mid-term and long-term financing of its FOCUS-27 [...]
Information marché Financement du projet de transformation FOCUS-27
06/06/2024
Communiqué de presse Paris – Le 6 juin 2024 – EUROAPI informe avoir décidé de se faire accompagner par un mandataire ad hoc dans les discussions entamées en février 2024 concernant le financement à moyen et long terme [...]
ACT Foundation congratulates Quebec Minister of Education on announcement to expand AEDs to all public schools
06/06/2024
OTTAWA, June 06, 2024 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation congratulates Education Minister Bernard Drainville for his announcement to ensure Automated External Defibrillators (AEDs) in [...]
La Fondation ACT salue la décision du ministre de l'Éducation du Québec d’étendre les défibrillateurs à toutes les écoles publiques
06/06/2024
OTTAWA, 06 juin 2024 (GLOBE NEWSWIRE) -- La Fondation (ACT) des soins avancés en urgence coronarienne accueille favorablement l’annonce faite par le ministre de l'Éducation, Bernard Drainville, visant à assurer la [...]
Barinthus Bio's VTP-300 Trials Demonstrate Ability to Achieve Undetectable HBsAg levels and Statistical Significance in Lowering HBsAg Levels in People with Chronic Hepatitis B
06/06/2024
In t he HBV003 trial, 67% of participants had HBsAg <10 IU/mL and 19% of participants had undetectable HBsAg when assessed for NUC discontinuation (end of treatment) or later, and 76% of participants were eligible [...]
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
06/06/2024
Data highlighted in oral presentation at the European Association for the Study of the Liver (EASL) Congress WARMISTER, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or [...]
Legend Senior Living Assumes Management, Renames Four Florida Properties, Increases Portfolio to 59
06/06/2024
WICHITA, Kan., June 06, 2024 (GLOBE NEWSWIRE) -- Legend Senior Living announced today that it has assumed management of four senior living residences in Florida, which increases the number of properties in the company's [...]
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
06/06/2024
CHATHAM, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), fully-integrated biopharmaceutical company with marketed products and a pipeline of development [...]
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
06/06/2024
iC³® is hosted by BioNTX in collaboration with Arlington Economic Development Corporation DALLAS, June 06, 2024 (GLOBE NEWSWIRE) -- BioNTX , the leading biotechnology and healthcare innovation trade organization in [...]
AssistRx Expands Tech + Talent Footprint with New Facilities in Florida and Kansas
06/06/2024
Additional space accommodates near-doubling of workforce to support innovative therapy initiation and patient support service offerings ORLANDO, Fla., June 06, 2024 (GLOBE NEWSWIRE) -- AssistRx , the advanced therapy [...]
U.S. Oral Surgery Management Secures New Partner Practices in Colorado, Kansas and California
06/06/2024
IRVING, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) continues its growth momentum, adding three new partner practices to its network of premier oral and maxillofacial surgeons. [...]
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
06/06/2024
HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of [...]
Streamline Today, Predict Tomorrow: MNDR's AI-Powered Health Operating System Optimizes Operations and Powers Predictive Healthcare
06/06/2024
SINGAPORE, June 06, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”) , a leading Asia-Pacific telehealth provider, today announces the latest major update to its cloud- [...]
Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study
06/06/2024
Total Patient Enrollment of 90 Towards Overall Target of 240 DALLAS, June 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused [...]
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day
06/06/2024
Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard of care for opioid overdose reversal in a community setting New topline survey findings reinforce the need for continued [...]
Aeroflow Health Announces Lactation Care Services are Now Available to Blue Cross Blue Shield Patients Across the Country
06/06/2024
Aeroflow continues to expand access to postpartum care for new mothers with in-network lactation resources for BCBS patients at little to no additional cost ASHEVILLE, N.C., June 06, 2024 (GLOBE NEWSWIRE) -- Aeroflow [...]
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
06/06/2024
Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months. FDA Allowance for an [...]
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
06/06/2024
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the time of [...]

Pages